REFILE-Avanir to be bought by Japan's Otsuka Pharmaceutical for $3.5 bln
(Adds dropped word 'said' in paragraph 1)
Dec 2 (Reuters) - Avanir Pharmaceuticals Inc said it agreed to be acquired by a unit of Japan's Otsuka Holdings Co Ltd for about $3.5 billion.
Otsuka Pharmaceutical Co Ltd will pay $17 per share in cash, representing a premium of 13.3 percent to Avanir's stock close on Monday. (Reporting by Neha Dimri in Bengaluru; Editing by Gopakumar Warrier)
© Thomson Reuters 2017 All rights reserved.